Features of Atrial Fibrillation in Patients with Arterial Hypertension and Extracardial Disorders

被引:1
|
作者
Khidirova, Lyudmila D. [1 ]
Yakhontov, David A. [1 ]
Zenin, Sergei A. [2 ]
Mamedov, Mehman N. [3 ]
机构
[1] Novosibirsk State Med Univ, Chair Pharmacol Clin Pharmacol & Evidence Based M, Krasny Prosp 52, Novosibirsk 630091, Russia
[2] Novosibirsk Reg Clin Cardiol Dispensary, Dept Surg Treatment Complex Cardiac Arrhythmias &, Zalesskogo Ul 6-8, Novosibirsk 630047, Russia
[3] Natl Med Res Ctr Prevent Med, Lab Interdisciplinary Approach Prevent Chron Nonc, Petroverigsky Per 10, Moscow 101990, Russia
关键词
atrial fibrillation; arterial hypertension; diabetes mellitus; obesity; thyroid gland; chronic obstructive pulmonary disease; PROGRESSION; PRESSURE; OBESITY;
D O I
10.20996/1819-6446-2019-15-3-368-373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study the features of the progression of atrial fibrillation (AF) in patients with arterial hypertension (HT) and comorbid extracardiac diseases. Material and methods. In the observational cohort study 308 men 45-65 years old with AF and HT were observed Most patients also had the following comorbid extracardiac diseases: diabetes mellitus (DM; n=40), diffuse toxic goiter (DTG; n=42); hypothyroidism (HTH; n=59), abdominal obesity (AO; n=64), and chronic obstructive pulmonary disease (COPD; n=47). The comparison group consisted of 56 patients with AF and HT only. Clinical, anthropometric, laboratory parameters, levels of NT-proBNP and galectin-3, results of ECG, daily monitoring of ECG and blood pressure were assessed initially and after 12 months. Results. Persistent AF (29.6-65.2%) and long-term persistent AF (16-31.3%) were more common in groups with extracardiac diseases compared with the AF+HT group (20.4% and 14.2%, respectively). Permanent form of AF was statistically significantly more common in the DM (11.1%), AO (14.8%) and HTH (6.2%) groups compared with the AF+HT group (0.6%). A comparative assessment of risk factors (smoking and alcohol) did not show significant differences in prevalence in the groups (22-44%). An assessment of the levels of fibrosis and remodeling markers found a statistically significant increase in the level of galectin-3 in groups of patients with concomitant extracardiac diseases and an increase in the NT-proBNP level, relative to reference values in all groups except DTG. Conclusion. Patients with AF in combination with HT and comorbid extracardiac diseases have a more rapid AF progression.
引用
收藏
页码:368 / 373
页数:6
相关论文
共 50 条
  • [21] Lymphocytes and monocytes subpopulations in blood of patients with atrial fibrillation or atrial flutter associated with arterial hypertension
    Ilchyshyna, O. Ya
    Sychov, O. S.
    Talaieva, T. V.
    Stasyshena, O. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 438 - 439
  • [22] Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation
    Dan, G. A.
    Badila, E.
    Weiss, E.
    Laroche, C.
    Boriani, G.
    Dan, A.
    Tavazzi, L.
    Maggioni, A. P.
    Crijns, H. J.
    Popescu, R.
    Blommaert, D.
    Streb, W.
    Lip, G. Y. H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 254 : 136 - 141
  • [23] FEATURES OF LIPID METABOLISM DISORDERS IN INDIVIDUALS WITH GENETIC PREDISPOSITION TO ARTERIAL HYPERTENSION AND PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION
    Kuzminova, Nataliia
    Ivankova, Anastasiia
    Stanislavchuk, Mykola
    Romanova, Valentyna
    Shapoval, Iryna
    Kulchytska, Olena
    Bilovol, Oleksandr
    Kniazkova, Iryna
    JOURNAL OF HYPERTENSION, 2024, 42
  • [24] Perindopril Arginin in the Management of Patients With Arterial Hypertension Associated With Paroxysmal Atrial Fibrillation
    Gosteva, E. V.
    Nikitin, A. V.
    Kobzev, S. N.
    KARDIOLOGIYA, 2014, 54 (12) : 17 - 21
  • [25] Immune status comparison in patients with atrial fibrillation or flutter on the base of arterial hypertension
    Ilchyshyna, O. Y. A.
    Sychov, O. S.
    Talaieva, T. V.
    Tretiak, I. V.
    Stasyshena, O. V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 360 - 360
  • [26] Is arterial stiffness a contributing factor to atrial fibrillation in patients with hypertension? A preliminary investigation
    Reiffel, JA
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (03) : 213 - 216
  • [27] THE EFFICACY OF CARVEDILOL IN THE THERAPY OF PATIENTS WITH TACHICARDIC FORM OF ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION
    Drambyan, M.
    Fljyan, N.
    Makaryan, Y.
    Poghosyan, E.
    JOURNAL OF HYPERTENSION, 2010, 28 : E60 - E60
  • [28] PECULIARITIES OF THE COURSE OF ATRIAL FIBRILLATION IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER A CORONAVIRUS INFECTION
    Stasyshena, Oksana
    Sychov, Oleg
    Romanova, Olena
    Getman, Taisia
    Sribna, Olga
    Mikhalieva, Tatiana
    Marchenko, Olena
    JOURNAL OF HYPERTENSION, 2023, 41 : E188 - E188
  • [29] Metalloproteinase activity of the blood in patients with arterial hypertension with paroxysmal form of atrial fibrillation
    Khezheva, F. M.
    Mazur, N. A.
    Masenko, V. P.
    KARDIOLOGIYA, 2007, 47 (12) : 10 - 14
  • [30] Atrial fibrillation in patients with clinical signs of heart failure due to arterial hypertension
    Yagensky, A
    Tseluiko, V
    Federov, Y
    Kostyk, S
    Dukhnevych, L
    JOURNAL OF HYPERTENSION, 2002, 20 : S219 - S219